Ketamine can produce experiences ranging from mild detachment to profound alterations in self, time, space and reality. At the deeper end of that spectrum, some people report experiences they describe as mystical or spiritual. Could the nature and depth of that altered state contribute to therapeutic outcomes—or is the experience simply accompanying a drug working through other mechanisms?
Alejandro's demanding career didn't become less demanding after ketamine treatment. The problems waiting for him at work didn't disappear. What changed, he says, was how long they followed him home. His experience raises a deceptively simple question: when circumstances remain the same, what does it mean to feel better?
After years of physical illness, anxiety and business stress, James returned to ketamine treatment having tried it once before. This time, he says, something felt different. But the change he values most isn't found in the treatment room. It's in traffic, music, watering plants—and even unloading the dishwasher.
Psychedelic medicine has moved from the scientific margins into serious clinical and regulatory development. But growing interest should not be confused with approval—and the evidence, legality and accessibility vary considerably from one substance to another.
Research in people facing cancer and other life-threatening illnesses suggests psilocybin may reduce anxiety, depression and existential distress. But what exactly is changing—and how strong is the evidence?
DMT can produce one of the strangest recurring phenomena in psychedelic research: encounters with apparently autonomous beings. Thousands of people describe them as intelligent, communicative and startlingly real. What can science actually tell us about these experiences?
IV ketamine is widely regarded as the gold-standard route for off-label racemic ketamine treatment in psychiatry. But ketamine can also be administered intramuscularly, intranasally, orally and sublingually—and esketamine is available as an FDA-approved nasal spray. These approaches are not interchangeable. Route changes the pharmacology, precision, monitoring and potentially the experience itself.
Children can be shaped by traumatic events they never personally experienced. Family dynamics, culture, stress biology and epigenetics may all play a role—but the popular idea that trauma is simply “passed through DNA” goes beyond what science has established.
Technology has given us extraordinary access to information, people and possibility. It has also created an environment engineered to compete relentlessly for our attention. The more useful question may no longer be whether technology is good or bad, but what it is doing to the way we think, connect and experience being human.
Ketamine changed depression research by demonstrating that psychiatric symptoms could sometimes improve within hours. Now researchers are investigating its potential across PTSD, OCD, addiction, eating disorders, sleep—and even neurological disease. Some applications are supported by meaningful human evidence. Others remain almost entirely experimental. Where does the science actually stand?
Psychedelics can radically alter perception, identity and our sense of reality. But drugs aren't the only way consciousness can change. Breathwork, meditation, hypnosis, sensory manipulation and even the boundary between waking and sleep reveal something stranger: the brain already possesses the machinery required to transform ordinary experience.